DrugPatentWatch Database PreviewSee Plans and Pricing
« Back to Dashboard
Eteplirsenis the generic ingredient in one branded drug marketed by Sarepta Theraps Inc and is included in one NDA. There are seven patents protecting this compound. Additional information is available in the individual branded drug profile pages.
Eteplirsen has one hundred and ninety-six patent family members in twenty-four countries.
One supplier is listed for this compound.
Recent Clinical Trials for eteplirsen
Identify potential brand extensions & 505(b)(2) entrants
|Sarepta Therapeutics||Phase 3|
|Sarepta Therapeutics||Phase 2|
|Sarepta Therapeutics||Phase 1/Phase 2|
Recent Litigation for eteplirsen
Identify potential future generic entrants
District Court Litigation
|University of Western Australia v. Academisch Ziekenhuis Leiden||2016-02-25|
Pharmacology for eteplirsen
|Drug Class||Antisense Oligonucleotide |
|Applicant||Tradename||Generic Name||Dosage||NDA||Approval Date||TE||Type||RLD||RS||Patent No.||Patent Expiration||Product||Substance||Delist Req.||Exclusivity Expiration|
|Sarepta Theraps Inc||EXONDYS 51||eteplirsen||SOLUTION;INTRAVENOUS||206488-002||Sep 19, 2016||RX||Yes||Yes||Start Trial||Start Trial||Y||Start Trial|
|Sarepta Theraps Inc||EXONDYS 51||eteplirsen||SOLUTION;INTRAVENOUS||206488-002||Sep 19, 2016||RX||Yes||Yes||Start Trial||Start Trial||Start Trial|
|Sarepta Theraps Inc||EXONDYS 51||eteplirsen||SOLUTION;INTRAVENOUS||206488-001||Sep 19, 2016||RX||Yes||Yes||Start Trial||Start Trial||Y||Start Trial|
|>Applicant||>Tradename||>Generic Name||>Dosage||>NDA||>Approval Date||>TE||>Type||>RLD||>RS||>Patent No.||>Patent Expiration||>Product||>Substance||>Delist Req.||>Exclusivity Expiration|
Make Better Decisions: Try a trial or see plans & pricing
Serving leading biopharmaceutical companies globally:
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.